Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma
Translational Research · 2024
DOI: 10.1016/j.trsl.2024.05.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Research, 2024. Verfasst von Erwin Tomasich und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I, Division of Oncology, Medical University of Vienna, Austria; Christian Doppler Laboratory for Personalized Immunotherapy, D…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, DNA Methylation, Stromal Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Christian Doppler Forschungsgesellschaft, Austrian National Foundation for Research Technology and Development, National Foundation for Science and Technology Development.
Abstract (Originalsprache)
The presence of abundant tumor stroma is a prominent characteristic of pancreatic ductal adenocarcinomas (PDAC) that potentially influences disease progression and therapy response. This study aims to investigate immune cell infiltration and epigenetic profiles in tumor cell enriched ("Tumor") and stroma cell enriched ("Stroma") regions within human PDAC tissue samples. By comparing those regions, we identified 25,410 differentially methylated positions (DMPs) distributed across 6,963 unique genes. Pathway enrichment analysis using the top 2,000 DMPs that were either hyper- or hypomethylated indicated that immune response pathways and the estrogen receptor pathway are epigenetically dysregulated in Tumor and Stroma regions, respectively. In terms of immune cell infiltration, we observed overall low levels of T cells in both regions. In Tumor regions however, occurrence of tumor-associated macrophages (TAMs) was higher than in Stroma regions (p = 0.02) concomitant with a dualistic distribution that stratifies PDAC patients into those with high and low TAM infiltration. By categorizing TAM levels into quartiles, our analysis revealed that PDAC patients with more than 1,515 TAMs per mm² exhibited significantly shorter overall survival (p = 0.036). Our data suggest that variations in inflammatory characteristics between the Tumor and Stroma defined compartments of PDAC may primarily stem from the presence of macrophages rather than lymphocytes. The abundance of TAMs within regions enriched with tumor cells correlates with patient survival, underscoring the potential significance of exploring therapeutic interventions targeting TAMs. Furthermore, directing attention towards the estrogen receptor pathway may represent a promising strategy to address the stroma cell component within the PDAC tumor microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine I, Division of Oncology, Medical University of Vienna, Austria; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Austria.
- Department of Surgery, Division of Visceral Surgery, Medical University of Vienna, Austria.
- Department of Pathology, Medical University of Vienna, Austria.
- Department of Medicine I, Division of Oncology, Medical University of Vienna, Austria.
- Department of Medicine I, Division of Oncology, Medical University of Vienna, Austria; Institute of Medical Statistics, Center for Medical Data Science, Medical University of Vienna, Austria.
- Department of Medicine I, Division of Oncology, Medical University of Vienna, Austria; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Austria. Electr…
Förderung
- Christian Doppler Forschungsgesellschaft
- Austrian National Foundation for Research Technology and Development
- National Foundation for Science and Technology Development
- Austrian Federal Government Ministry of Digital and Economic Affairs
- Medizinische Universität Wien
Zitieren
APA
Tomasich, E., Mühlbacher, J., Wöran, K., Hatziioannou, T., Herac, M., Kleinberger, M., Berger, J. M., Dibon, L. K., Berchtold, L., Heller, G., Bergen, E. S., Macher-Beer, A., Prager, G., Schindl, M., Preusser, M., & Berghoff, A. S. (2024). Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma. Translational Research. https://doi.org/10.1016/j.trsl.2024.05.005
Vancouver
Tomasich E, Mühlbacher J, Wöran K, Hatziioannou T, Herac M, Kleinberger M, et al. Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma. Translational Research. 2024. doi:10.1016/j.trsl.2024.05.005
BibTeX
@article{Tomasich2024,
author = {Tomasich, Erwin and Mühlbacher, Jakob and Wöran, Katharina and Hatziioannou, Teresa and Herac, Merima and Kleinberger, Markus and Berger, Julia Maria and Dibon, Lea Katharina and Berchtold, Luzia and Heller, Gerwin and Bergen, Elisabeth Sophie and Macher-Beer, Andrea and Prager, Gerald and Schindl, Martin and Preusser, Matthias and Berghoff, Anna Sophie},
title = {Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma},
journal = {Translational Research},
year = {2024},
doi = {10.1016/j.trsl.2024.05.005}
}
EUVIMED